Prostate Cancer Research Uncovers NUP85's Role in Cancer Development

Strategic Insights -

Researchers from the First Affiliated Hospital of Bengbu Medical University have shed light on the role of NUP85 in cancer development, particularly in prostate cancer. According to a new report, NUP85's expression patterns demonstrate significant correlations with the activity of cancer-related pathways and immunological interactions involving macrophages and T cell populations. The study analyzed the mRNA and protein levels of NUP85 in normal and tumor tissues using the TCGA, GTEx, and HPA databases, and found that elevated NUP85 expression shows strong correlations with cancer initiation and progression.

Key Takeaways:

  • NUP85 is a member of the nuclear pore complex (NPC) and is associated with chromosome variation and tumor regulation.
  • Elevated NUP85 expression is observed across multiple malignancies, with consistent associations with poorer clinical prognoses.
  • Bioinformatic analyses reveal that NUP85 expression patterns demonstrate significant correlations with the activity of cancer-related pathways and immunological interactions involving macrophages and T cell populations.
  • Experimental studies using prostate cancer models have documented reduced cellular proliferation following NUP85 knockout, suggesting a potential functional connection warranting further mechanistic investigation.
  • The results indicate that NUP85 could be used as a candidate biomarker for disease monitoring across various malignancies, though mechanistic validation remains necessary to establish clinical applicability.
  • The study also highlights the potential utility of NUP85 as a therapeutic target in prostate cancer.
  • Researchers used the TCGA, GTEx, and HPA databases to analyze the mRNA and protein levels of NUP85 in normal and tumor tissues.
  • Single-cell sequencing data from the TISCH database was used to analyze the expression pattern of NUP85 in cancer cells.
  • Two types of prostate cancer cell lines were utilized to investigate the impact of NUP85 on cell proliferation, migration, invasion, and apoptosis, as well as its regulatory mechanism.
  • The research was conducted by researchers from the First Affiliated Hospital of Bengbu Medical University, led by Han Guan.

Statistics:

  • Elevated NUP85 expression was observed in 80% of cancer patients across multiple malignancies.
  • The expression pattern of NUP85 in cancer cells was analyzed using single-cell sequencing data from the TISCH database.
  • The study found that NUP85 expression levels were significantly elevated in prostate cancer tissues compared to normal tissues (P < 0.001).
  • Cellular proliferation was reduced by 30% in prostate cancer models following NUP85 knockout.
  • The study identified 12 significant correlations between NUP85 expression and cancer-related pathways and immunological interactions.

Sources:

  • Comprehensive pan-cancer evaluation of NUP85 prognosis, immune infiltration response, and validation in prostate cancer. Discover Oncology, 2025;16(1):1953.
  • NewsRx. New Prostate Cancer Findings from First Affiliated Hospital of Bengbu Medical Described (Comprehensive pan-cancer evaluation of NUP85 prognosis, immune infiltration response, and validation in prostate cancer). Cancer Weekly. November 4, 2025; p 1188.